查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032997

經皮貼片市場規模、佔有率、趨勢和預測：按類型、分銷管道、應用和地區分類，2026-2034年

Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球經皮貼片市場規模為85億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以3.54%的複合年成長率成長，到2034年達到117億美元。目前，北美市場佔據主導地位，預計2025年將佔據35.5%的市場。由於先進的醫療基礎設施，以及創新經皮吸收技術的支撐，該市場持續成長。慢性病的高發生率推動了對有效、非侵入性治療方法的持續需求。此外，製藥公司的強大實力和有利的法規結構也促進了產品研發和監管核准，鞏固了該地區在全球經皮貼片市場的重要地位。

經皮貼片是一種非侵入性且易於使用的給藥方式，可在預定時間內將穩定且持續的治療劑量藥物輸送到血液中。這些貼劑由基材、藥物、薄膜、黏合劑、襯墊、化學促進劑和滲透促進劑、物理輔助劑以及微弱電流（例如離子導入）組成。其擴散速率取決於皮膚特性和貼片設計。目前，透皮貼片已在全球廣泛應用於化妝品、外用藥物和經皮給藥系統等領​​域。

經皮貼片市場的發展趨勢：

經皮貼片可有效治療心臟病、荷爾蒙失調、偏頭痛、帕金森氏症、阿茲海默症、中風、愛滋病、免疫力缺乏不寧腿症候群。因此，這些疾病患者人數的顯著增加是推動市場成長的主要動力。此外，這些貼劑有助於避免傳統的口服給藥，減少靜脈注射或腸外給藥的不便，並預防胃腸道毒性、噁心和嘔吐。其便利的使用方式也使經皮貼片成為提高患者長期用藥依從性、治療慢性疼痛和戒菸的理想選擇。此外，對更經濟有效的治療方法的需求不斷成長，以及各類藥物臨床試驗數量的顯著增加，也對市場產生了積極影響。此外，引入壓敏膠黏合劑和滲透增強劑以改善產品擴散和藥物保留，預計將在未來幾年為市場相關人員創造有前景的商業機會，從而推動經皮貼片應用在全球範圍內的擴張。

市場區隔:

本報告分析了全球經皮貼片市場各細分領域的關鍵趨勢，並提供了2026年至2034年的全球、區域和國家特定預測。該報告根據類型、分銷管道和應用對市場進行了細分。

按類型細分：

  • 單層型（含藥黏合劑）
  • 多層含藥黏合劑
  • 矩陣
  • 其他

依分銷管道分類：

  • 醫院藥房
  • 零售藥房
  • 網路商店

按用途細分：

  • 緩解疼痛
  • 戒菸和戒菸支持
  • 膀胱過動症
  • 荷爾蒙療法
  • 其他

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

就該產業的競爭格局而言，主要公司包括 3M 公司、AdhexPharma、LTS Lohmann Therapie-Systeme AG、綠葉製藥集團、Medherant Limited、日東電工株式會社、Noven Pharmaceuticals Inc.（久會製藥、株式製藥公司、Prosolus Inc.、三株製藥公司持股、Tapemarks（Tapemarks）、aapemarks Inc.、三株製藥公司製藥公司（Tapemarks）、aapemarks Inc.、三株製藥公司製藥公司（Tapemarks）、Tapemarks Inc.、三株製藥公司製藥公司（Tapemarks）、aapemarks Inc.、三株式製藥公司（Tapemarks）、aapemarks Inc.、三株製藥公司製藥公司（Tapemarks）、Ateskape； SE（拜爾斯道夫股份公司）和梯瓦製藥工業有限公司。

本報告解答的主要問題

1.經皮貼片市場規模有多大？

2.經皮貼片市場的未來前景如何？

3. 推動經皮貼片市場發展的主要因素是什麼？

4.經皮貼片市場中，哪個地區佔最大的市佔率？

5. 全球經皮貼片市場的主要參與者有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球經皮貼片市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 單層含藥黏合劑
  • 多層含藥黏合劑
  • 矩陣
  • 其他

第7章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路商店

第8章 市場區隔：依應用領域分類

  • 緩解疼痛
  • 減少吸菸和戒菸支持
  • 膀胱過動症
  • 荷爾蒙療法
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc.（Hisamitsu Pharmaceutical Co. Inc.）
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc.（Teikoku Seiyaku Co. Ltd）
    • tesa SE（Beiersdorf AG）
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112026A5142

The global transdermal skin patches market size was valued at USD 8.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 11.7 Billion by 2034, exhibiting a CAGR of 3.54% during 2026-2034. North America currently dominates the market, holding a significant market share of 35.5% in 2025. The market is experiencing growth because of advanced healthcare infrastructure supporting innovative transdermal technologies. High prevalence of chronic conditions ensures sustained demand for effective, non-invasive treatment options. Besides this, strong presence of pharmaceutical companies and favorable regulatory frameworks drive product development and regulatory approvals, solidifying the region's significance in the global transdermal skin patches market share.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global transdermal skin patches market report, along with forecasts at the global, regional and country level from 2026-2034. The report categorizes the market based on type, distribution channel and application.

Breakup by Type:

  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by Application:

  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Overactive Bladder
  • Hormonal Therapy
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. How big is the transdermal skin patches market?

2. What is the future outlook of transdermal skin patches market?

3. What are the key factors driving the transdermal skin patches market?

4. Which region accounts for the largest transdermal skin patches market share?

5. Which are the leading companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2025
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 81: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players